66 related articles for article (PubMed ID: 24296883)
1. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
Brown AK; Carapellucci J; Oshrine B; Gomez A; Meoded A; Asante-Korang A
Clin Transplant; 2023 Sep; 37(9):e15015. PubMed ID: 37237443
[TBL] [Abstract][Full Text] [Related]
3. The role of
Wang C; Wang G; Wang W; Kan Y; Zhang M; Yang J
Quant Imaging Med Surg; 2024 Feb; 14(2):1323-1334. PubMed ID: 38415126
[TBL] [Abstract][Full Text] [Related]
4.
Chen J; Zhang X; Ma L; Gao Y; Fu Z; Liu M
Front Med (Lausanne); 2023; 10():1258310. PubMed ID: 37663666
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Role of FDG PET/CT in Pediatric Patients With Chronic Recurrent Multifocal Osteomyelitis.
Xu Y; Wang G; Wang Y; Wang W; Kan Y; Yang J
Clin Nucl Med; 2024 Jun; 49(6):536-539. PubMed ID: 38598512
[TBL] [Abstract][Full Text] [Related]
6. Multimodality imaging features, treatment, and prognosis of post-transplant lymphoproliferative disorder in renal allografts: A case report and literature review.
Li J; Liu Y; Wang Z; Hu X; Xu R; Qian L
Medicine (Baltimore); 2018 Apr; 97(17):e0531. PubMed ID: 29703027
[TBL] [Abstract][Full Text] [Related]
7. 18 F-FDG PET/CT in Renal Allograft Tuberculosis Mimicking as Posttransplant Malignancy.
Moideen A; Singh H; Kumar R; Naik SM; Gupta A; Sekar A; Nada R
Clin Nucl Med; 2024 Feb; 49(2):e52-e53. PubMed ID: 38049975
[TBL] [Abstract][Full Text] [Related]
8. Slowly Expanding 18 F-FDG PET-Positive Irregular Opacities in the Lung Due to Diffuse Lymphoid Hyperplasia Preceding Rheumatoid Arthritis.
Sumitomo K; Okamoto T; Arii K; Matumoto M; Shinohara T
Clin Nucl Med; 2023 Jun; 48(6):542-544. PubMed ID: 37083578
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings.
Hoyt D; Hughes J; Liu J; Ayyad H
Radiol Case Rep; 2024 Jun; 19(6):2168-2182. PubMed ID: 38515768
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder.
Chow TK
Clin Nucl Med; 2023 Jun; 48(6):534-535. PubMed ID: 37083567
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT Findings of Renal Cell Carcinoma Arising From a Transplanted Kidney in a Pediatric Patient.
Fleury AS; Zhuang H
Clin Nucl Med; 2023 Dec; 48(12):e605-e607. PubMed ID: 37844572
[TBL] [Abstract][Full Text] [Related]
12. Role of
Shrinivas Y; Palaniswamy SS; Subramanyam P
World J Nucl Med; 2024 Mar; 23(1):49-53. PubMed ID: 38595838
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of
Gutiérrez-Villanueva A; Quintana-Reyes C; Martínez de Antonio E; Rodríguez-Alfonso B; Velásquez K; de la Iglesia A; Bautista G; Escudero-Gómez C; Duarte R; Fernández-Cruz A
Microorganisms; 2024 Jan; 12(2):. PubMed ID: 38399711
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 pandemic on 2-[
Maurea S; Bombace C; Mainolfi CG; Annunziata A; Attanasio L; Stanzione A; Matano E; Mucci B; D'Ambrosio A; Giordano C; Petretta M; Del Vecchio S; Cuocolo A
Heliyon; 2022 Jan; 8(1):e08819. PubMed ID: 35097234
[TBL] [Abstract][Full Text] [Related]
15. [
Deleuziere M; Benoist É; Quelven I; Gras E; Amiens C
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611815
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Radiological Evaluation of and Theranostics for Glioblastoma.
Hooper GW; Ansari S; Johnson JM; Ginat DT
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627190
[TBL] [Abstract][Full Text] [Related]
17.
Borges-Rosa J; Oliveira-Santos M; Silva R; Elvas L; Ferreira MJ; Gonçalves L
J Nucl Cardiol; 2024 Jan; ():101794. PubMed ID: 38190936
[No Abstract] [Full Text] [Related]
18. Post-Renal Transplant Lymphoproliferative Disorder.
Jain Y; Purandare N; Agrawal A; Shah S; Puranik A; Rangarajan V
Radiol Imaging Cancer; 2024 Jan; 6(1):e230075. PubMed ID: 38063506
[No Abstract] [Full Text] [Related]
19. Inpatient FDG PET/CT: Counterpoint-A Costly Yet Subpar Evaluation That Prolongs Hospital Length of Stay.
Dietsche E; Scaringi J
AJR Am J Roentgenol; 2024 Jan; ():. PubMed ID: 38197757
[No Abstract] [Full Text] [Related]
20. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
Metser U; Lo G
Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
